gloveharicut

gloveharicut | Joined since 2020-06-02

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

455

Threads

1,067

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
1,067
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-11-17 10:42 | Report Abuse

If you worry on GLOVES & vaccine news

This is how I hedge my risk

How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to TASCO Cold Chain to hedge vaccine news
How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to FREIGHT to hedge vaccine news
KGB's dry ice plant to flourish from Pfizer's vaccine success?

https://klse.i3investor.com/blogs/gloveharicut/blidx.jsp

Stock

2020-11-17 10:42 | Report Abuse

If you worry on GLOVES & vaccine news

This is how I hedge my risk

How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to TASCO Cold Chain to hedge vaccine news
How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to FREIGHT to hedge vaccine news
KGB's dry ice plant to flourish from Pfizer's vaccine success?

https://klse.i3investor.com/blogs/gloveharicut/blidx.jsp

Stock

2020-11-17 10:42 | Report Abuse

If you worry on GLOVES & vaccine news

This is how I hedge my risk

How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to TASCO Cold Chain to hedge vaccine news
How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to FREIGHT to hedge vaccine news
KGB's dry ice plant to flourish from Pfizer's vaccine success?

https://klse.i3investor.com/blogs/gloveharicut/blidx.jsp

Stock

2020-11-17 10:42 | Report Abuse

If you worry on GLOVES & vaccine news

This is how I hedge my risk

How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to TASCO Cold Chain to hedge vaccine news
How to distribute the ultra-cold vaccine? I am allocating my GLOVE profit to FREIGHT to hedge vaccine news
KGB's dry ice plant to flourish from Pfizer's vaccine success?

https://klse.i3investor.com/blogs/gloveharicut/blidx.jsp

Stock

2020-11-10 11:40 | Report Abuse

https://klse.i3investor.com/blogs/gloveharicut/2020-11-10-story-h1535719004-GLOVES_party_End_You_should_ask_how_to_distribute_the_ultra_cold_vaccin.jsp

But the vaccine’s complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.

“This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature.”

Stock

2020-11-10 11:40 | Report Abuse

https://klse.i3investor.com/blogs/gloveharicut/2020-11-10-story-h1535719004-GLOVES_party_End_You_should_ask_how_to_distribute_the_ultra_cold_vaccin.jsp

But the vaccine’s complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.

“This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature.”

Stock

2020-11-10 11:40 | Report Abuse

https://klse.i3investor.com/blogs/gloveharicut/2020-11-10-story-h1535719004-GLOVES_party_End_You_should_ask_how_to_distribute_the_ultra_cold_vaccin.jsp

But the vaccine’s complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.

“This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature.”

Stock

2020-11-10 11:40 | Report Abuse

https://klse.i3investor.com/blogs/gloveharicut/2020-11-10-story-h1535719004-GLOVES_party_End_You_should_ask_how_to_distribute_the_ultra_cold_vaccin.jsp

But the vaccine’s complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.

“This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature.”

News & Blogs

2020-11-10 11:39 | Report Abuse

But the vaccine’s complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.

“This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature.”